The Globe and Mail

Branded Pharmaceutical Stocks Report Mixed Q4 Results Amid Industry Challenges and Opportunities As the pharmaceutical industry navigates a landscape of innovation and regulatory pressures, recent fourth-quarter earnings reports reveal a …

Spotify Q1 2026 Earnings Preview: Key Expectations and What Investors Should Know Spotify Technology S.A. (SPOT) is set to report its first-quarter 2026 financial results on April 28, before the …

Understanding Microsoft Azure: The Engine of Modern Cloud Computing In the modern digital economy, the ability to scale infrastructure rapidly without investing in massive physical hardware is a competitive necessity. …

Adia Nutrition Launches Clinical Study to Evaluate AdiaVita for Autism Spectrum Disorder Adia Nutrition has announced a major partnership with a leading clinic in Atlanta to initiate a groundbreaking clinical …

Nvidia’s Strategic Pivot: Navigating AI Policy and the $1 Trillion Opportunity Nvidia continues to sit at the center of the artificial intelligence revolution, balancing explosive growth opportunities against complex geopolitical …

Aurinia Pharmaceuticals: Advancing the Frontier of Autoimmune Disease Treatment For patients living with autoimmune diseases, the search for effective, targeted therapies is often a race against time. Aurinia Pharmaceuticals Inc. …

To create a comprehensive and factually accurate article based on the provided information and instructions, we will focus on generating content that incorporates verified claims and authoritative sources. Here’s the …

Scaling Intelligence: Inside Uber AI Solutions Uber is expanding its operational footprint beyond ride-sharing and delivery, positioning itself as a critical infrastructure provider for the artificial intelligence era. Through Uber …

Meta’s $27 Billion AI Infrastructure Deal with Nebius Signals Shift in Cloud Computing Meta Platforms is making a substantial investment in artificial intelligence infrastructure, signing a five-year agreement with Nebius …